The recent development of gDNA-based NGS assays for parallel analysis of CRC predisposing genes (including MMR genes, APC and MUTYH tested in this study) opens a new possibility for more efficient genetic screening of HNPCC at reasonable costs. This evidence concerns the gene MRC1 and colorectal carcinoma.